Drug Pipeline Quarterly Update: September 2021

Drugs in review, drugs with expiring patents, generic availability and more.

September 30, 2021

These quarterly pipeline wrap-ups include new molecular entity approvals, drugs with approvable status from the FDA, potential blockbuster drugs and the dates of expected FDA approval, names of top selling brand-name drugs with generic availability in the past 12 months and names of top selling brand-name drugs that have patents expiring soon.

September 2021 Quarterly Drug Pipeline Update
September 2021 Quarterly Specialty Drug Pipeline Update

Related news

Perspectives

June 14, 2024

High-Cost Therapy Profile: June 2024

Detailed information about Imetelstat Intravenous (IV)

Perspectives

June 14, 2024

July 2024 decisions expected from the FDA

Your monthly synopsis of new drugs expected to hit the market

Perspectives

May 30, 2024

Drug Approvals Monthly Update: May 2024

This monthly update of United States (U.S.) Food and Drug Administration (FDA) approvals…